Streetbeat News

Revenues

CRL

Charles River (NYSE:CRL) has seen varied analyst ratings over the past three months, with a recent shift towards more positive evaluations. The average 12-month price target for CRL has increased by 6.93% to $273.29, reflecting a positive outlook from analysts. Key financial indicators show Charles River facing challenges in revenue growth and debt management, but excelling in net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 12:00 pm

RXRX

Recursion Pharmaceuticals (NASDAQ:RXRX) has been the subject of 4 analyst reviews over the past three months, showing a generally bullish outlook with an average 12-month price target of $16.75, marking an 11.67% increase from the previous target of $15.00. The company, a clinical-stage biotech firm, has seen a -22.32% decline in revenue growth and boasts a net margin of -875.34%, indicating strong profitability despite its revenue challenges.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 12:00 pm

OSK

Recent analysis of Oshkosh (NYSE:OSK) by 9 financial analysts shows a mix of bullish and bearish sentiments, with an updated average 12-month price target of $139.44, reflecting a 7.26% increase from the previous target. The company's financial performance indicates solid revenue growth and efficient cost management, despite challenges in utilizing equity capital efficiently.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 12:00 pm

SEDG

SolarEdge Technologies (NASDAQ:SEDG) has seen a diverse range of analyst ratings over the past three months, with a notable shift towards more cautious or negative outlooks in the last 30 days. The average 12-month price target for SEDG has been adjusted to $76.38, marking a 10.42% decrease from the previous target of $85.26. This adjustment reflects a broader sentiment of caution among analysts, who have predominantly lowered their price targets and ratings based on the company's recent performance and market dynamics. SolarEdge's financial overview indicates challenges in revenue growth, profitability, and asset utilization, with a significant decline in revenue and below-average net margin and ROE.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 12:00 pm

LKQ

LKQ Corporation has signed an agreement to sell its subsidiary Elit Polska in Poland to Meko AB. Elit Polska, which reported a revenue of approximately $107M in 2023, is expected to complete the transaction in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 11:44 am

EVLV

Evolv Technologies Holdings' shares dropped following the announcement of disappointing Q1 financial results and a reduction in its FY24 sales forecast, falling below analyst expectations.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 11:35 am

SHCO

Soho House projects its FY24 revenue to be between $1.2 billion and $1.25 billion, aligning closely with the estimated $1.24 billion.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 11:34 am

SNGX

Soligenix reported revenues of $100K for the quarter ended March 31, with an EPS of $(0.18).

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 11:34 am

OSG

Overseas Shipholding Group (OSG) reported a 35.71% increase in Q1 EPS to $0.19 from $0.14 YoY and a 3.26% increase in sales to $117.50M from $113.79M YoY.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 11:34 am

CERS

GWH

SABR

Insiders at ESS Tech, Cerus, and Sabre have recently made significant stock purchases, signaling potential confidence in their companies' futures. ESS Tech's director bought shares following a narrower quarterly loss, Cerus saw an increase in product revenue, and Sabre reported strong first-quarter results with an updated revenue outlook.

Portfolio Pulse from Avi Kapoor

May 10, 2024 | 11:21 am